E-LIB Suche - Ergebnisse für: Di Giacomo, Anna Maria

1

Immunotherapy of mesothelioma: the evolving change of a lon..:

Calabrò, Luana ; Bronte, Giuseppe ; Grosso, Federica...
Frontiers in Immunology. 14 (2024) - p. , 2024

2

The future of targeting cytotoxic T-lymphocyte-associated p..:

Di Giacomo, Anna Maria ; Lahn, Michael ; Eggermont, Alexander MM...
European Journal of Cancer. 198 (2024) - p. 113501 , 2024

Link: https://doi.org/10.1016/..

3

Immunotherapy in melanoma: Can we predict response to treat..:

Splendiani, Elena ; Besharat, Zein Mersini ; Covre, Alessia...
Pharmacology & Therapeutics. 256 (2024) - p. 108613 , 2024

Link: https://doi.org/10.1016/..

4

Epigenetic remodeling to improve the efficacy of immunother..:

Lofiego, Maria Fortunata ; Piazzini, Francesca ; Caruso, Francesca Pia...
Journal of Translational Medicine. 22 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

5

Corrigendum to "Nivolumab plus ipilimumab in melanoma patie..:

Di Giacomo, Anna Maria ; Chiarion-Sileni, Vanna ; Del Vecchio, Michele...
European Journal of Cancer. 202 (2024) - p. 113981 , 2024

Link: https://doi.org/10.1016/..

6

Prognostic and predictive value of non-steroidal anti-infla..:

Kennedy, Oliver John ; Glassee, Nina ; Kicinski, Michal...
European Journal of Cancer. 201 (2024) - p. 113585 , 2024

Link: https://doi.org/10.1016/..

7

Nivolumab plus ipilimumab in melanoma patients with asympto..:

Di Giacomo, Anna Maria ; Chiarion-Sileni, Vanna ; Del Vecchio, Michele...
European Journal of Cancer. 199 (2024) - p. 113531 , 2024

Link: https://doi.org/10.1016/..

8

Combined immunotherapy in melanoma patients with brain meta..:

Mandalà, Mario ; Lorigan, Paul ; Sergi, Maria Chiara...
European Journal of Cancer. 199 (2024) - p. 113542 , 2024

Link: https://doi.org/10.1016/..

9

Discontinuation of anti-PD1 in advanced melanoma: an observ..:

Rubatto, Marco ; Fava, Paolo ; Stanganelli, Ignazio...
European Journal of Cancer. 187 (2023) - p. 25-35 , 2023

Link: https://doi.org/10.1016/..

10

Guadecitabine plus ipilimumab in unresectable melanoma: fiv..:

Noviello, Teresa Maria Rosaria ; Di Giacomo, Anna Maria ; Caruso, Francesca Pia...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

11

Prognostic and predictive value of metformin in the Europea..:

Kennedy, Oliver John ; Kicinski, Michal ; Valpione, Sara...
European Journal of Cancer. 189 (2023) - p. 112900 , 2023

Link: https://doi.org/10.1016/..

12

Rational Use of Monoclonal Antibodies as Therapeutic Treatm..:

Cusi, Maria Grazia ; Di Giacomo, Anna Maria ; Anichini, Gabriele...
Viruses. 15 (2023) 3 - p. 614 , 2023

Link: https://doi.org/10.3390/..

13

Safety of extended interval dosing immune checkpoint inhibi..:

Cantini, Luca ; Paoloni, Francesco ; Pecci, Federica...
JNCI: Journal of the National Cancer Institute. 115 (2023) 7 - p. 796-804 , 2023

Link: https://doi.org/10.1093/..

14

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/..:

Larkin, James ; Del Vecchio, Michele ; Mandalá, Mario...
Clinical Cancer Research. 29 (2023) 17 - p. 3352-3361 , 2023

Link: https://doi.org/10.1158/..

15

From Co-Stimulation to Co-Inhibition: A Continuum of Immuno..:

Simonetti, Elena ; Cutarella, Serena ; Valente, Monica...
OncoTargets and Therapy. 16 (2023) - p. 227-232 , 2023

Link: https://doi.org/10.2147/..